title: Vasopressin: if some is good, is more better?
authors.affiliation: Dr. Frishman is the Associate Division Director in the Division of Reproductive Endocrinology and Infertility, Women & Infants' Hospital, and Professor in the Department of Obstetrics and Gynecology, Brown Alpert Medical School, Providence, Rhode Island; e-mail: Gary_Frishman@Brown.edu.
authors.forename: Gary
authors.initials: G
authors.lastname: Frishman
mesh_terms: D016063:Blood Loss, Surgical / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D054796:Drug Dosage Calculations; D005260:Female; D013509:Gynecologic Surgical Procedures; D006490:Hemostatics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007273:Injections, Intramuscular; D017410:Practice Guidelines as Topic; D014667:Vasopressins / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D006490:Hemostatics; D014667:Vasopressins